e-learning
resources
ERJ
2011
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The effect of dornase alfa on ventilation inhomogeneity in patients with cystic fibrosis
Amin R., Subbarao P., Lou W., Jabar A., Balkovec S., Jensen R., Kerrigan S., Gustafsson P., Ratjen F.
Source:
Eur Respir J 2011; 37: 806-812
Journal Issue:
April
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Amin R., Subbarao P., Lou W., Jabar A., Balkovec S., Jensen R., Kerrigan S., Gustafsson P., Ratjen F.. The effect of dornase alfa on ventilation inhomogeneity in patients with cystic fibrosis. Eur Respir J 2011; 37: 806-812
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cystic fibrosis and intestinal organoids
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Novel therapeutics for cystic fibrosis
Related content which might interest you:
The effect of rhDNase on ventilation inhomogeneity in patients with cystic fibrosis
Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more
Year: 2010
The influence of dornase alfa on long-term lung function in cystic fibrosis
Source: Eur Respir J 2001; 18: Suppl. 33, 538s
Year: 2001
Improved treatment response to dornase alfa in cystic fibrosis patients using controlled inhalation
Source: Eur Respir J 2011; 38: 1328-1335
Year: 2011
Short-term effects of physiotherapy on ventilation inhomogeneity in cystic fibrosis patients with moderate to severe lung disease
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013
Effects of dornase alfa and hypertonic saline on gas mixing in lung periphery in children with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014
Noninvasive ventilation in cystic fibrosis patients with acute or chronic respiratory failure
Source: Eur Respir J 2002; 19: 310-313
Year: 2002
Evaluation of ventilation maldistribution as an early indicator of lung disease in children with cystic fibrosis
Source: Eur Respir J 2003 Dec 01;22(6):972-979
Year: 2003
Long term non invasive positive pressure ventilation is associated with a stabilisation in the decline of lung function in patients with cystic fibrosis
Source: Annual Congress 2006 - Interventions and outcome in chronic respiratory failure - new aspects and deeper insights
Year: 2006
Short-term effect of autogenic drainage on ventilation inhomogeneity in adults with stable non-cystic fibrosis bronchiectasis
Source: International Congress 2016 – Physiotherapy management of the ill but spontaneously-breathing adult patient
Year: 2016
Acute effect of exercise on ventilation inhomogeneity in adult cystic fibrosis patients
Source: International Congress 2017 – Exercise testing in cardiorespiratory diseases
Year: 2017
The effect of Simeox airway clearance technology on resting hyperinflation in Cystic fibrosis patients
Source: Virtual Congress 2020 – New insights into respiratory physiotherapy
Year: 2020
Tidal expiratory flow limitation and chronic dyspnoea in patients with cystic fibrosis
Source: Eur Respir J 2002; 19: 492-498
Year: 2002
Non-invasive ventilation in non cystic fibrosis bronchiectasis
Source: International Congress 2016 – Noninvasive ventilation and beyond: novelties and real-life applications
Year: 2016
Long-term repeatability of ventilation inhomogeneity in healthy infants and those with cystic fibrosis (CF)
Source: Annual Congress 2004 - Cystic fibrosis in the 21
st
century: cutting edge investigations, taxing problems
Year: 2004
Effect of different physiotherapy devices on ventilation distribution in adults with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013
Noninvasive positive pressure ventilation in patients with acute exacerbation of idiopathic pulmonary fibrosis
Source: Annual Congress 2006 - Pulmonary fibrosis: pathophysiology and therapeutic approaches
Year: 2006
High frequency chest wall oscillation (HFCWO) in the treatment of acute pulmonary exacerbation in adult cystic fibrosis (CF) patients
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013
Home non-invasive ventilation (HNIV) improves survival in hypercapnic patients with cystic fibrosis
Source: Annual Congress 2012 - Current trends in home mechanical ventilation
Year: 2012
Lung clearance index in cystic fibrosis subjects treated for pulmonary exacerbations
Source: Eur Respir J 2015; 46: 1055-1064
Year: 2015
RhDNase after airway clearance therapy improves peripheral airway patency in children with cystic fibrosis
Source: Annual Congress 2006 - Cystic fibrosis lung disease: molecules images and drugs
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept